Abstract
The process of stigmatization associated with TB has been undervalued in national research as this social aspect is important in the control of the disease, especially in marginalized populations. This paper introduces the stages of the process of cultural adaptation in Brazil of the Tuberculosis-related stigma scale for TB patients. It is a methodological study in which the items of the scale were translated and back-translated with semantic validation with 15 individuals of the target population. After translation, the reconciled back-translated version was compared with the original version by the project coordinator in Southern Thailand, who approved the final version in Brazilian Portuguese. The results of the semantic validation conducted with TB patients enable the identification that, in general, the scale was well accepted and easily understood by the participants.
Highlights
The stigma associated with tuberculosis (TB) is a social phenomenon present in several cultures and communities[1]
This study is a methodological investigation consisting of the process of translation and semantic validation of the items of the Tuberculosis-related stigma scale developed and validated in Southern Thailand
According to the Human Development Index (HDI) of 0.80, literacy rate of 3.0, and the São Paulo Social Vulnerability Index (IPVS), the city is in the group of those presenting good social and economic indicators[18,19]
Summary
The stigma associated with tuberculosis (TB) is a social phenomenon present in several cultures and communities[1]. The moral change after the identification of its pathogen by Robert Koch, as well as the confirmation of its transmissivity, contributed to evidence certain social categories as the only ones to be affected by the disease[2]. This is due to the fact that the spread of TB was more prevalent among the poor due to their precarious life conditions in large industrial cities in the late nineteenth and early twentieth centuries, conditions which contributed to infection and development of the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have